Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

4.42
Delayed Data
As of Mar 02
 -0.10 / -2.21%
Today’s Change
4.31
Today|||52-Week Range
15.95
-3.07%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close4.52
Today’s open4.48
Day’s range-- - --
Volume16,683
Average volume (3 months)54,940
Market cap$49.0M
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...+0.12+5.01%
HEBHemispherx Biopharma...+0.01+2.88%
ONTXOnconova Therapeutic...-0.01-0.44%
ENZNEnzon Pharmaceutical...+0.05+4.76%
Data as of 03/02/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account